Logo

Steven Paul

Nov 16, 2006
Premium
Sigma-Aldrich has appointed Steven Paul as a company director.
 
Paul is currently executive vice president for science and technology at Eli Lilly and president of the Lilly Research Laboratories. Previously, he served as scientific director of the National Institute of Mental Health.

Filed under

Gene Silencing/Gene Editing
RNAi
Breaking News
The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.